Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)

NEXT STORY
MediciNova Announces Plans to Initiate a Clinical Trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)
PREV STORY
KRONOS ADVANCED TECHNOLOGIES INC ANNOUNCES EXCLUSIVE MANUFACTURING AND DISTRIBUTION AGREEMENT FOR A NEW LINE OF AIR DISINFECTION PRODUCTS
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ryzodeg® offers a simpler solution with once-daily dosing and reduced risk of nocturnal hypoglycaemia vs insulin glargine U100 plus insulin aspart

Berlin, Germany, 2 October 2018 ­- When treated with once-daily Ryzodeg®, people with type ...

author_avatar
NASDAQ Market News

Karyopharm Publishes Preclinical and Phase 1 Clinical Data for Selinexor in Ovarian Cancer in Clinical Cancer Research Publication

- XPO1 Inhibition Significantly Reduced Tumor Burden in Platinum Sensitive and Resistant Ovarian Cancer ...

author_avatar
NASDAQ Market News

BeyondSpring Provides Operational Updates and First-Quarter 2018 Financial Results

NEW YORK, June 21, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the Company) (NASDAQ:BYSI), a ...

author_avatar
NASDAQ Market News